Mitchell B. Balter

1.4k total citations
27 papers, 1.1k citations indexed

About

Mitchell B. Balter is a scholar working on Experimental and Cognitive Psychology, Clinical Psychology and Psychiatry and Mental health. According to data from OpenAlex, Mitchell B. Balter has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Experimental and Cognitive Psychology, 9 papers in Clinical Psychology and 8 papers in Psychiatry and Mental health. Recurrent topics in Mitchell B. Balter's work include Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Substance Abuse Treatment and Outcomes (6 papers). Mitchell B. Balter is often cited by papers focused on Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (9 papers), Child and Adolescent Psychosocial and Emotional Development (8 papers) and Substance Abuse Treatment and Outcomes (6 papers). Mitchell B. Balter collaborates with scholars based in United States, Czechia and Japan. Mitchell B. Balter's co-authors include E. H. Uhlenhuth, Dean I. Manheimer, Jerome Levine, Glen D. Mellinger, David N. Nurco, Kenneth C. C. Yang, Thomas A. Ban, J Levine, Ira H. Cisin and Arthur J. Bonito and has published in prestigious journals such as Science, New England Journal of Medicine and American Journal of Psychiatry.

In The Last Decade

Mitchell B. Balter

27 papers receiving 896 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitchell B. Balter United States 19 428 237 233 218 188 27 1.1k
A. Dobler-Mikola Switzerland 17 334 0.8× 276 1.2× 410 1.8× 398 1.8× 91 0.5× 34 1.3k
Charles T. Kaelber United States 13 267 0.6× 217 0.9× 471 2.0× 202 0.9× 55 0.3× 18 1.2k
Vito Agosti United States 20 270 0.6× 364 1.5× 348 1.5× 360 1.7× 120 0.6× 35 1.1k
Nicholas Seivewright United Kingdom 19 306 0.7× 457 1.9× 577 2.5× 288 1.3× 52 0.3× 45 1.3k
Martha Sanchez‐Craig United States 22 330 0.8× 301 1.3× 325 1.4× 1.0k 4.8× 167 0.9× 35 1.8k
Suzette Glasner‐Edwards United States 15 215 0.5× 261 1.1× 434 1.9× 358 1.6× 105 0.6× 21 1.2k
Gerald F.X. Feeney Australia 21 297 0.7× 382 1.6× 453 1.9× 450 2.1× 97 0.5× 74 1.3k
Hamid Ghodse United Kingdom 18 171 0.4× 94 0.4× 287 1.2× 298 1.4× 92 0.5× 69 909
Juha Veijola Finland 15 222 0.5× 341 1.4× 410 1.8× 83 0.4× 130 0.7× 33 1.4k
Jeffrey S. Markowitz United States 14 629 1.5× 472 2.0× 722 3.1× 84 0.4× 183 1.0× 22 1.5k

Countries citing papers authored by Mitchell B. Balter

Since Specialization
Citations

This map shows the geographic impact of Mitchell B. Balter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitchell B. Balter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitchell B. Balter more than expected).

Fields of papers citing papers by Mitchell B. Balter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitchell B. Balter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitchell B. Balter. The network helps show where Mitchell B. Balter may publish in the future.

Co-authorship network of co-authors of Mitchell B. Balter

This figure shows the co-authorship network connecting the top 25 collaborators of Mitchell B. Balter. A scholar is included among the top collaborators of Mitchell B. Balter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitchell B. Balter. Mitchell B. Balter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Uhlenhuth, E. H., Mitchell B. Balter, Thomas A. Ban, & Kenneth C. C. Yang. (1999). International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: VI. Trends in recommendations for the pharmacotherapy of anxiety disorders, 1992-1997. Depression and Anxiety. 9(3). 107–116. 48 indexed citations
2.
Uhlenhuth, E. H., Mitchell B. Balter, Thomas A. Ban, & Kenneth C. C. Yang. (1999). International Study of Expert Judgment on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications: IV. Therapeutic Dose Dependence and Abuse Liability of Benzodiazepines in the Long-Term Treatment of Anxiety Disorders. Journal of Clinical Psychopharmacology. 19(6 Suppl 2). 23S–29S. 49 indexed citations
3.
Uhlenhuth, E. H., Mitchell B. Balter, T. A. Ban, & Kenneth C. C. Yang. (1999). Trends in recommendations for the pharmacotherapy of anxiety disorders by an international expert panel, 1992–1997. European Neuropsychopharmacology. 9. S393–S398. 17 indexed citations
4.
Uhlenhuth, E. H., Mitchell B. Balter, Thomas A. Ban, & Kenneth C. C. Yang. (1998). International Study of Expert Judgment on Therapeutic Use of Benzodiazepines and Other Psychotherapeutic Medications. Journal of Clinical Psychopharmacology. 18(6 Suppl 2). 27S–31S. 15 indexed citations
5.
Uhlenhuth, E. H., Mitchell B. Balter, Thomas A. Ban, & Kenneth C. C. Yang. (1995). International study of expert judgement on therapeutic use of benzodiazepines and other psychotherapeutic medications: II. Pharmacotherapy of anxiety disorders. Journal of Affective Disorders. 35(4). 153–162. 27 indexed citations
6.
Uhlenhuth, E. H., Mitchell B. Balter, T. A. Ban, & Kenneth C. C. Yang. (1995). International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: III. Clinical features affecting experts' therapeutic recommendations in anxiety disorders.. PubMed. 31(2). 289–96. 15 indexed citations
7.
Uhlenhuth, E. H., Mitchell B. Balter, & Glen D. Mellinger. (1993). Clinical variables in pharmacoepidemiology. Journal of Psychiatric Research. 27. 89–95. 6 indexed citations
8.
Balter, Mitchell B. & E. H. Uhlenhuth. (1992). Prescribing and Use of Benzodiazepines: An Epidemiologic Perspective. Journal of Psychoactive Drugs. 24(1). 63–64. 7 indexed citations
9.
Shader, Richard I., David J. Greenblatt, & Mitchell B. Balter. (1991). Appropriate Use and Regulatory Control of Benzodiazepines. The Journal of Clinical Pharmacology. 31(9). 781–784. 37 indexed citations
10.
Nurco, David N., et al.. (1991). A Classification of Narcotic Addicts Based on Type, Amount and Severity of Crime. Journal of Drug Issues. 21(2). 429–448. 24 indexed citations
11.
Nurco, David N. & Mitchell B. Balter. (1990). A plan aimed at the prevention and treatment of drug dependence. Drug and Alcohol Dependence. 25(2). 193–197. 2 indexed citations
12.
Uhlenhuth, E. H., Harriet de Wit, Mitchell B. Balter, Chris E. Johanson, & Glen D. Mellinger. (1988). Risks and Benefits of Long-Term Benzodiazepine Use. Journal of Clinical Psychopharmacology. 8(3). 161???167–161???167. 68 indexed citations
13.
Balter, Mitchell B., et al.. (1983). Evaluating a household survey measure of psychic distress. Psychological Medicine. 13(3). 607–622. 31 indexed citations
14.
Mellinger, Glen D., et al.. (1982). Assessing Comprehension in a Survey of Public Reactions to Complex Issues. Public Opinion Quarterly. 46(1). 97–97. 9 indexed citations
15.
Wheatley, David, et al.. (1975). Psychiatric Aspects of Hypertension. The British Journal of Psychiatry. 127(4). 327–336. 45 indexed citations
16.
Nurco, David N., et al.. (1975). Studying Addicts over Time: Methodology and Preliminary Findings. The American Journal of Drug and Alcohol Abuse. 2(2). 183–196. 97 indexed citations
17.
Balter, Mitchell B., Jerome Levine, & Dean I. Manheimer. (1974). Cross-National Study of the Extent of Anti-Anxiety/Sedative Drug Use. New England Journal of Medicine. 290(14). 769–774. 164 indexed citations
18.
Manheimer, Dean I., et al.. (1973). Popular Attitudes and Beliefs About Tranquilizers. American Journal of Psychiatry. 130(11). 1246–1253. 47 indexed citations
19.
Manheimer, Dean I., Glen D. Mellinger, & Mitchell B. Balter. (1969). Marijuana Use Among Urban Adults. Science. 166(3912). 1544–1545. 43 indexed citations
20.
Manheimer, Dean I., Glen D. Mellinger, & Mitchell B. Balter. (1968). Psychotherapeutic drugs. Use among adults in California.. PubMed. 109(6). 445–51. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. Dobler-Mikola Breakdown of academic impact, for papers by Charles T. Kaelber Breakdown of academic impact, for papers by Vito Agosti Breakdown of academic impact, for papers by Nicholas Seivewright Breakdown of academic impact, for papers by Martha Sanchez‐Craig Breakdown of academic impact, for papers by Suzette Glasner‐Edwards Breakdown of academic impact, for papers by Gerald F.X. Feeney Breakdown of academic impact, for papers by Hamid Ghodse Breakdown of academic impact, for papers by Juha Veijola Breakdown of academic impact, for papers by Jeffrey S. Markowitz
Rankless by CCL
2026